FDA Approves TNKase for Acute Ischemic Stroke
By Lori Solomon HealthDay Reporter
.jpg?width=1200)
THURSDAY, March 6, 2025 -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
TNKase is delivered as a single five-second intravenous bolus. This is considerably faster than the standard of care, Activase (alteplase), which is administered as an intravenous bolus followed by a 60-minute infusion. Genentech, the manufacturer of TNKase, says a new 25-mg vial configuration will be available in the coming months.
The approval is based on a study comparing TNKase to Activase in patients with acute ischemic stroke who presented with a disabling neurological deficit. Results show that TNKase was comparable to Activase in terms of efficacy and safety.
Stroke affects more than 795,000 people each year in the United States. It is the leading cause of long-term disability and the fifth leading cause of death. Since brain damage occurs and progresses rapidly during an acute ischemic stroke, immediate, fast-acting medical care is vital.
"Today's approval is a significant step forward and underscores our commitment to advancing stroke treatment options for patients," Levi Garraway, M.D., Ph.D., the chief medical officer and head of global product development at Genentech, said in a statement. "TNKase provides a faster and simpler administration, which can be critical for anyone who is dealing with an acute stroke."
Approval of TNKase was granted to Genentech.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
7 Doctor-Approved Tips for Outdoor Fitness Without Injury
SUNDAY, June 22, 2025 — Spending time outside walking, hiking or running is a great way to stay healthy during the summer. But before you jump into a new routine, health...
How a Baby’s Brain Grows in the First Years of Life
SATURDAY, June 21, 2025 — The first two years of a baby’s life are critical for brain development, and how the brain grows during that time may help predict future...
Chicken Alfredo Meals Recalled After Listeria Outbreak Kills 3
FRIDAY, June 20, 2025 — Premade chicken fettuccine Alfredo meals sold at Walmart and Kroger have been recalled amid a listeria outbreak that sickened 17 people and led to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.